Section 8.5 (Estimated quarters of funding available) of the 2Q21 has 6.3 quarters where as 3Q21 it was 3.0
So significant cash burn reduction. While not yet giving guidance on cash flow positive, it is promising to see this moving towards this goal.
Disappointing the shareprice movement of late, and revenue is less this quarter than previous quarter, however, the news flow has been very intermittent. Does look like the "initiate go to market strategy" planned for Jan 2021 was ahead of schedule (December) and they are delivering on the product expansion phase. Hopefully good things ahead...
- Forums
- ASX - By Stock
- FMR
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FMR (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.598M |
Open | High | Low | Value | Volume |
17.0¢ | 18.0¢ | 17.0¢ | $1.2K | 7.042K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18189 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 59899 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18189 | 0.170 |
5 | 88303 | 0.165 |
2 | 61400 | 0.160 |
1 | 60000 | 0.155 |
1 | 100000 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 59899 | 2 |
0.190 | 3333 | 1 |
0.195 | 25000 | 1 |
0.200 | 12767 | 2 |
0.205 | 20000 | 1 |
Last trade - 15.59pm 09/10/2024 (20 minute delay) ? |
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
FMR (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online